About
Dr. Brandi C. Vann has served on the 908 Devices board since August 2025, appointed to fill the vacancy created by Jeffrey George's resignation. She is Vice President and Chief Strategy Officer at Charles Stark Draper Laboratories and spent more than fifteen years at the U.S. Department of Defense, including performing the duties of Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs. She received her Ph.D. in Chemistry from the University of South Carolina.
Roles
908 Devices Inc.
Director · Current role
August 2025–present
Charles Stark Draper Laboratories
Vice President and Chief Strategy Officer
March 2026 - present
U.S. Department of Defense
Performing the Duties of Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs
April 2024 - July 2025
U.S. Department of Defense
Principal Deputy Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs
January 2022 - July 2025
Director Compensation
FY 2025Fees earned or paid in cash
$16,667
ComponentBoard and committee cash retainers earned in FY2025
Stock awards
$100,004
ComponentInitial one-time RSU award (joined the board August 1, 2025), ASC 718 grant-date fair value
Option awards
$99,959
ComponentInitial one-time NQSO award (joined the board August 1, 2025), ASC 718 grant-date fair value
Total
$216,630
Also at 908 Devices Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.